Arylamine N-acetyltransferase: A possible promoter in Helicobacter pylori-related gastric carcinogenesis

Chinese Medical Journal (Taipei)

Volumn 62, Issue 4, 1999, Pages 203-208

  Hung, Chi Fu ^a,c   Chung, Jing Gung ^a   Liu, Su Ing ^a   Hung, Hygeia ^b  

^a JEN AI HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Arylamine; Gastric cancer; Helicobacter pylori; N acetyltransferase

Indexed keywords

ACETYL COENZYME A; ARYLAMINE ACETYLTRANSFERASE;

ADULT; AGED; ARTICLE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; XENOBIOTIC METABOLISM;

ACETYLATION; ADOLESCENT; ADULT; AGED; ARYLAMINE N-ACETYLTRANSFERASE; CARCINOGENS; DNA; HELICOBACTER PYLORI; HUMANS; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 0032919748     PISSN: 05781337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulcération. Lancet 1984;1:1311-5.
2. Moller H, Heseltine E, Vainio H. Working group report on schistosomes, liver flukes and Helicobacter pylori. Int J Cancer 1995;60:587-9.
3. Loffeld RJ, Willems L, Flendrig JA, Arenas JW. Helicobacter pylon and gastric carcinoma. Histopathology 1990;17: 537-41.
4. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Hehcobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. New Engl J Med 1991;325:1132-6.
5. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N. Helicobacter pylori infection and the risk of gastric carcinoma. New Engl J Med 1991;325: 1127-31.
6. Sivaprakash R, Rao UA, Thyagaraian SP, Ramathilakam B, Jayanthi V. Investigation for the prevalence of Helicobacter pylori infection in patients with gastric carcinoma in Madras, India, Jpn J Med Sci Biol 1996;49:49-56.
7. Kadlubar FF. Carcinogenic aromatic amine metabolism and DNA adduct detection in humans. Princess Takamatsu Symp 1990;21:329-38.
8. Turesky RJ, Lang NP, Butler MA, Teitel CH, Kadlubar FF. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis 1991;12: 1839-45.
9. Lang NP, Chu DZ, Hunter CF, Kendall DC, Flammang TJ, Kadlubar FF. Role of aromatic amine acetyltransferase in human colorectal carcinoma. Arch Surg 1986;121: 1259-61.
10. Weber WW, Hein DW. N-acetylation pharmacogenetics. Pharmacol Rev 1985;37:25-79.
11. Ho CC, Lin TH, Lai YS, Levy GN, Weber WW. Kinetics of acetyl coenzyme A: arylamine N-acetyltransferase from rapid and slow acetylator frog tissues. Drug Metab Dispos 1996;24:137-41.
12. Chung JG, Kuo HM, Lin TH, Ho CC, Lee JH, Lai JM, et al. Evidence for arylamine N-acetyltransferase in the Nematode Anisakis simplex. Cancer Lett 196;106:1-8.
13. Andres HH, Klem AJ, Szabo SM, Weber WW. New spectrophotometric and radiochemical assays for acetyl-CoA: arylamine N-acetyltransferase applicable to a wide variety of arylamines. Anal Biochem 1985;145:367-75.
14. Mattano SS, Weber WW. Kinetic of arylamine N-acetyltransferase in tissues from rapid and slow acetylator mice. Carcinogenesis 1987;8:133-7.
15. Martell KJ, Levy GN, Weber WW. Cloned mouse N-acetyltransferase: enzymatic properties of expressed Nat-1 and Nat-2 gene products. Mol Pharmacol 1992;42:265-72.
16. Chung JG, Wang HH, Tsou MF, Hsieh HH, Lo HH, Yen YS, et al. Evidence for arylamine N-acetyltransferase in the bacterium Helicobacter pylori. Toxic Lett 1997;91:63-71.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilization of the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
18. McGuigan JE. Helicobacter pylori: the versatile pathogen. Digest Dis 1996;14:289-303.
19. Meeda H, Sato K, Akaike T. Superoxide radical generation from heterocyclic amines. Princess Takamatsu Symp 1995; 23:103-12.
20. Halter F, Hurlimann S, Inauen W. Pathophysiology and clinical relevance of Helicobacter pylori. Yale J Biol Med 1992;65:626-38.
21. Kato J, Tomminga S, Ito Y. A prospective study of atropine gastritis and stomach cancer risk. Jpn J Cancer Res 1992;83: 1137-42.
22. Forman D. Helicobacter pylori and gastric cancer. Scand J Gastroenterol 1996;31:48-51.
23. Baik SC, Youn HS, Chung MH, Lee WK, Cho MJ, Ko GH, et al. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res 1996; 56:1279-82.
24. Tsujii M, Kawano S, Tsuji S, Nagano K, Ito T, Hayashi N, et al. Ammonia: a possible promoter in Helicobacter pylori-related gastric carcinogenesis. Cancer Lett 1992;65:15-8.
25. Sidebotham RL, Batten JJ, Karim QN, Spencer J, Baron JH. Breakdown of gastric mucus in presence of Helicobacter pylori J Clin Pathol 1991;26:52-7.
26. Figura N. Helicobacter pylori exotoxins and gastroduodenal diseases associated with cytotoxic strain infection. Aliment Pharma Ther 1996;10:79-96.
27. Ruiz B, Rood JC, Fontham ET, Malcom GT, Hunter FM, Sobhan M, et al. Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment. Am J Gastroenterol 1994;89:535-9.
28. Hein DW, Rustan TD, Bucher KD, Furman EJ, Martin WJ. Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model. J Pharmacol Exp Ther 1991;258:232-6.
29. Flammang TJ, Yamazoe Y, Guengerich FP, Kadlubar FF. The S-acetyl coenzyme A-dependent metabolic activation for the carcinogen N-hydroxy-2-aminofluorene by human liver cytosol and its relationship to the aromatic amine N-acetyltransferase phenotype. Carcinogenesis 1987;8: 1967-70.
30. Ross RK, Jones PA, Yu MC. Bladder cancer epidemiology and pathogenesis. Semin Oncol 1996;23:536-45.
31. Vineis P, McMichael A. Interplay between heterocyclic amines in cooked meat and metabolic phenotype in the etiology of colon cancer. Cancer Cause Control 1996;7: 479-86.